Sphera Funds Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Sphera Funds Management's BLUE Position: Q1 2020 in Review
Sphera Funds Management sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 4,979 shares — an estimated $5.66M sold.
Sphera Funds Management first reported a position in BLUE in Q4 2013 and held it in 11 quarters. The position peaked at $13.8M in Q4 2018. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.
- Sphera Funds Management reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
- Sphera Funds Management sold 4,979 bluebird bio shares in Q1 2020, an estimated $5.66M.
- Sphera Funds Management first reported a position in bluebird bio in Q4 2013 and held it in 11 quarters.
- Sphera Funds Management's bluebird bio position peaked at $13.8M in Q4 2018.
- 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.
Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.